CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

O'Shaughnessy Ventures Backs Bioengineer Developing Injectable Blood Vessels

Positive
AI Analysis

Summary

O'Shaughnessy Ventures awarded a fellowship to bioengineer Liam Aranda-Michel to develop an injectable blood vessel therapy that restores circulation without major surgery. This is an early-stage funding announcement for a novel therapeutic approach in vascular engineering.

Importance:2/10
Sentiment:
0.60
fundingbioengineeringinjectable therapyvascular engineeringearly stage
Related Companies

Read the original article

Published by PR Newswire Biotech on July 7, 2026 12:36 PM

Read Original